These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10544774)

  • 21. Primary breast carcinoma: immunocytochemical and immunohistochemical evaluation of biological parameters.
    Sianesi M; Bozzetti C; Del Rio P; Nizzoli R; Cascinu S
    Chir Ital; 2000; 52(6):643-5. PubMed ID: 11199998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women.
    Rao AV; Mohammed WA; Ragoonanan C; Omo-Igbinomwanhia NE
    West Indian Med J; 2002 Mar; 51(1):4-9. PubMed ID: 12089875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
    Kaufmann M; Hortobagyi GN; Goldhirsch A; Scholl S; Makris A; Valagussa P; Blohmer JU; Eiermann W; Jackesz R; Jonat W; Lebeau A; Loibl S; Miller W; Seeber S; Semiglazov V; Smith R; Souchon R; Stearns V; Untch M; von Minckwitz G
    J Clin Oncol; 2006 Apr; 24(12):1940-9. PubMed ID: 16622270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France].
    MacGrogan G; Mathieu MC; Poulet B; Penault-Llorca F; Vincent-Salomon A; Roger P; Treilleux I; Valent A; Antoine M; Becette V; Bor C; Brabencova E; Charafe-Jauffret E; Chenard MP; Dauplat MM; Delrée P; Devouassoux M; Fiche M; Fondrevelle ME; Fridman V; Garbar C; Genin P; Ghnassia JP; Haudebourg J; Laberge-Le Couteulx S; Loussouarn D; Maran-Gonzalez A; Marcy M; Michenet P; Sagan C; Trassard M; Verriele V; Arnould L; Lacroix-Triki M;
    Ann Pathol; 2014 Oct; 34(5):366-72. PubMed ID: 25439989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of HER-2/neu in breast carcinoma].
    Skálová A; Vanĕcek T; Losan F; Papoutsidesová ; Fínek J
    Cas Lek Cesk; 2003 Feb; 142(2):93-8. PubMed ID: 12698536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colocalization of estrogen and progesterone receptors with an estrogen-regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue.
    Ciocca DR; Stati AO; Amprino de Castro MM
    Breast Cancer Res Treat; 1990 Oct; 16(3):243-51. PubMed ID: 2085675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commentary: hormone receptor testing in breast cancer: a distress signal from Canada.
    Allred DC
    Oncologist; 2008 Nov; 13(11):1134-6. PubMed ID: 18987048
    [No Abstract]   [Full Text] [Related]  

  • 31. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
    Schulze MH; Buchmann J
    Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunohistochemical research on breast cancer cell proliferation and hormonal receptor status with special emphasis on HER-2/neu expression].
    Ohlinger R; Steffen SM; Oellig F; Köhler G; Schwesinger G; Lorenz G
    Zentralbl Gynakol; 2002 Oct; 124(10):473-7. PubMed ID: 12712389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between telomerase activity and hormone receptor status and p53 expression in breast cancer.
    Mokbel K; Ghilchik M; Williams G; Akbar N; Parris C; Newbold R
    Int J Surg Investig; 2000; 1(6):509-16. PubMed ID: 11729859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite instability correlates with negative expression of estrogen and progesterone receptors in sporadic breast cancer.
    Caldés T; Perez-Segura P; Tosar A; de La Hoya M; Diaz-Rubio E
    Teratog Carcinog Mutagen; 2000; 20(5):283-91. PubMed ID: 10992275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of oestrogen and progesterone receptors in freeze-dried, paraffin-embedded sections of breast cancer.
    Onetti-Muda A; Crescenzi A; Pujia N; Faraggiana T; Marinozzi V
    Histopathology; 1991 Jun; 18(6):511-6. PubMed ID: 1879811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of interlaboratory results of immunohistochemical techniques].
    Losi L; Ragazzini T
    Pathologica; 1997 Jun; 89(3):282-7. PubMed ID: 9380422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantifying estrogen and progesterone receptor expression in breast cancer by digital imaging.
    Szeszel MK; Crisman CL; Crow L; McMullen S; Major JM; Natarajan L; Saquib A; Feramisco JR; Wasserman LM
    J Histochem Cytochem; 2005 Jun; 53(6):753-62. PubMed ID: 15928324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
    Rocha R; Nunes C; Rocha G; Oliveira F; Sanches F; Gobbi H
    Pathol Res Pract; 2008; 204(9):655-62. PubMed ID: 18565685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?
    Arnould L; Coudert B; Fumoleau P
    J Clin Oncol; 2009 Jun; 27(16):2733; author reply 2734-5. PubMed ID: 19380432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.